Brian M. Feldman

30.2k total citations · 4 hit papers
326 papers, 14.6k citations indexed

About

Brian M. Feldman is a scholar working on Hematology, Rheumatology and Speech and Hearing. According to data from OpenAlex, Brian M. Feldman has authored 326 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Hematology, 81 papers in Rheumatology and 71 papers in Speech and Hearing. Recurrent topics in Brian M. Feldman's work include Autoimmune and Inflammatory Disorders Research (99 papers), Adolescent and Pediatric Healthcare (70 papers) and Inflammatory Myopathies and Dermatomyositis (56 papers). Brian M. Feldman is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (99 papers), Adolescent and Pediatric Healthcare (70 papers) and Inflammatory Myopathies and Dermatomyositis (56 papers). Brian M. Feldman collaborates with scholars based in Canada, United States and United Kingdom. Brian M. Feldman's co-authors include Earl D. Silverman, Ivan Diamond, Simon C. Ling, Paul W. Wales, Paul B. Pencharz, Aideen M. Moore, Robert C. Grant, Rayfel Schneider, Lisa G. Rider and Ronald M. Laxer and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Brian M. Feldman

315 papers receiving 14.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies

2014 1.8k citations Ivan Diamond, Robert C. Grant et al. Journal of Clinical Epidemiology profile →
WFH Guidelines for the Management of Hemophilia, 3rd edition

2020 1.1k citations Manuel Carção, Brian M. Feldman et al. profile →
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

2012 448 citations Brian M. Feldman et al. profile →
Distinctions Between Diagnostic and Classification Criteria?

2015 299 citations Sindhu R. Johnson, Hermine I. Brunner et al. profile →

Peers

Countries citing papers authored by Brian M. Feldman

Since Specialization

Citations

This map shows the geographic impact of Brian M. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Feldman more than expected).

Fields of papers citing papers by Brian M. Feldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Feldman. The network helps show where Brian M. Feldman may publish in the future.

Co-authorship network of co-authors of Brian M. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Feldman. A scholar is included among the top collaborators of Brian M. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Feldman. Brian M. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlation Between Interferon Response Gene Score and Disease Activity in Juvenile Dermatomyositis 2025 ·The Journal of Rheumatology ·(unknown), Mohammad Massumi, Trang T. Duong, (unknown), (unknown), (unknown), (unknown), Y. Ingrid Goh, Rae S. M. Yeung, Brian M. Feldman	2
2	Teaching Adolescents With Type 1 Diabetes Self-Compassion (TADS) to Reduce Diabetes Distress: Protocol for a Randomized Controlled Trial 2023 ·JMIR Research Protocols ·(unknown), Alexandra Ahmet, Karen Bluth, Brian M. Feldman, Ellen B Goldbloom, Gary S. Goldfield, Sarah Hamilton, (unknown), (unknown), Karine Khatchadourian, Sarah Lawrence, (unknown), Kuan Liu, (unknown), (unknown), Jai Shah, (unknown), (unknown), Marie‐Eve Robinson	1
3	The pediatric glucocorticoid toxicity index 2022 ·Seminars in Arthritis and Rheumatism ·Paul Brogan, Ray Naden, Stacy P. Ardoin, (unknown), Fabrizio De Benedetti, (unknown), Despina Eleftheriou, Brian M. Feldman, (unknown), (unknown), Fiona Price-Kuehne, David Skuse, Constantine A. Stratakis, Nicholas J.A. Webb, John H. Stone	6
4	Early Abnormal Nailfold Capillary Changes Are Predictive of Calcinosis Development in Juvenile Dermatomyositis 2022 ·The Journal of Rheumatology ·Tomo Nozawa, (unknown), (unknown), (unknown), Ophir Vinik, Rachel Shupak, (unknown), Brian M. Feldman	6
5	Developing guidelines for ultrarare rheumatic disorders: a bumpy ride 2022 ·Annals of the Rheumatic Diseases ·David Piskin, Micol Romano, Daniel Aletaha, Brian M. Feldman, Raphaela Goldbach‐Mansky, Loreto Carmona, Erkan Demirkaya	4
6	Electronic forms for patient reported outcome measures (PROMs) are an effective, time-efficient, and cost-minimizing alternative to paper forms 2021 ·Pediatric Rheumatology ·(unknown), (unknown), Nicholas Lao, Brian M. Feldman, Y. Ingrid Goh	20
7	Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis 2020 ·Journal of Medical Internet Research ·Jennifer Stinson, Chitra Lalloo, Amos Hundert, Sarah Campillo, Tania Cellucci, Paul Dancey, Ciarán M. Duffy, Janet Ellsworth, Brian M. Feldman, Adam M. Huber, Nicole Johnson, G. Majella de Jong, Kiem Oen, Alan Rosenberg, Natalie J. Shiff, Lynn Spiegel, Shirley M. L. Tse, Lori B. Tucker, J. Charles Victor	19
8	Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis 2020 ·The Journal of Rheumatology ·Maya Gerstein, (unknown), (unknown), Brian M. Feldman, (unknown), Deborah M. Levy, (unknown), Mohamed Abdelhaleem, Earl D. Silverman, Linda T. Hiraki	12
9	Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST) 2018 ·Clinical Trials ·Peter A. Nigrović, Timothy Beukelman, George Tomlinson, Brian M. Feldman, Laura E. Schanberg, Yukiko Kimura	17
10	Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A 2014 ·Journal of General Internal Medicine ·(unknown), Lusine Abrahamyan, Andrew R. Willan, Joseph Beyene, M. McLimont, Victor S. Blanchette, Brian M. Feldman	12
11	Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies breakdown → 2014 ·Journal of Clinical Epidemiology ·Ivan Diamond, Robert C. Grant, Brian M. Feldman, Paul B. Pencharz, Simon C. Ling, Aideen M. Moore, Paul W. Wales	1824
12	The Relationship Between Physical Activity Levels and Pain in Children with Juvenile Idiopathic Arthritis 2013 ·The Journal of Rheumatology ·(unknown), (unknown), Brian M. Feldman	37
13	Saudade: Longing and Desire in the Brazilian Soul 2013 ·The San Francisco Jung Institute Library Journal ·Brian M. Feldman	2
14	Determinants of quality of life in children with chronic somatic disease: pilot data from the GapS Questionnaire 2012 ·Quality of Life Research ·Bryn D. Webb, Maru Barrera, Joseph Beyene, Manuel Carção, Denis Daneman, Irene Elliott, (unknown), Ilana Halperin, (unknown), (unknown), Unni Narayanan, S. Ota, Melinda Solomon, Lillian Sung, Nancy L. Young, Mary Zachos, Brian M. Feldman	4
15	Quality of randomized clinical trials in juvenile idiopathic arthritis 2008 ·Lara D. Veeken ·Lusine Abrahamyan, Sindhu R. Johnson, Joseph Beyene, P. S. Shah, Brian M. Feldman	5
16	Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study 2006 ·Journal of Thrombosis and Haemostasis ·Brian M. Feldman, Menaka Pai, Georges‐Étienne Rivard, Sara J. Israels, M.‐C. Poon, C. Demers, (unknown), K. H. Luke, John K. Wu, (unknown), David Lillicrap, Paul Babyn, M. McLimont, Victor S. Blanchette	192
17	Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach 2005 ·Lara D. Veeken ·Athimalaipet V Ramanan, Rayfel Schneider, Michelle Batthish, Camille Achonu, S. Ota, M. McLimont, Nancy L. Young, Brian M. Feldman	17
18	European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood‐onset systemic lupus erythematosus 2003 ·Arthritis Care & Research ·Hermine I. Brunner, Earl D. Silverman, Claire Bombardier, Brian M. Feldman	46
19	Clinical assessment of conjunctival and episcleral vessel tortuosity in juvenile dermatomyositis 2002 ·Journal of American Association for Pediatric Ophthalmology and Strabismus ·Tara A. Young, (unknown), Brian M. Feldman, Alex V. Levin	3
20	Teachers’ Beliefs About Administrators and Parents of Handicapped and Nonhandicapped Students 1989 ·The Journal of Experimental Education ·David B. Feldman, Lawrence H. Gerstein, Brian M. Feldman	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact